| Interactome mapping reveals the evolutionary history of the nuclear pore complex SO Obado, M Brillantes, K Uryu, W Zhang, NE Ketaren, BT Chait, ... PLoS biology 14 (2), e1002365, 2016 | 101 | 2016 |
| Structure, dynamics, evolution, and function of a major scaffold component in the nuclear pore complex P Sampathkumar, SJ Kim, P Upla, WJ Rice, J Phillips, BL Timney, ... Structure 21 (4), 560-571, 2013 | 60 | 2013 |
| Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ... Elife 10, e73027, 2021 | 48 | 2021 |
| Structural determinants defining the allosteric inhibition of an essential antibiotic target TPS da Costa, S Desbois, C Dogovski, MA Gorman, NE Ketaren, ... Structure 24 (8), 1282-1291, 2016 | 42 | 2016 |
| From knock-out phenotype to three-dimensional structure of a promising antibiotic target from Streptococcus pneumoniae C Dogovski, MA Gorman, NE Ketaren, J Praszkier, LM Zammit, ... PLoS One 8 (12), e83419, 2013 | 29 | 2013 |
| Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes PC Fridy, MK Thompson, NE Ketaren, MP Rout Analytical biochemistry 477, 92-94, 2015 | 21 | 2015 |
| Purification and analysis of endogenous human RNA exosome complexes M Domanski, P Upla, WJ Rice, KR Molloy, NE Ketaren, DL Stokes, ... Rna 22 (9), 1467-1475, 2016 | 16 | 2016 |
| Crystallization of dihydrodipicolinate synthase from a clinical isolate of Streptococcus pneumoniae NE Sibarani, MA Gorman, C Dogovski, MW Parker, MA Perugini Acta Crystallographica Section F: Structural Biology and Crystallization …, 2010 | 14 | 2010 |
| Nanobody repertoires for exposing vulnerabilities of SARS-CoV-2 FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ... BioRxiv, 2021 | 10 | 2021 |
| Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2 FR Cross, PC Fridy, NE Ketaren, FD Mast, S Li, JP Olivier, K Pecani, ... Journal of Biological Chemistry 299 (3), 2023 | 4 | 2023 |
| Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus NE Ketaren, FD Mast, PC Fridy, JP Olivier, T Sanyal, A Sali, BT Chait, ... Elife 12, RP89423, 2024 | 1 | 2024 |
| Interactome mapping to reveal deep evolutionary events: The trypanosome nuclear pore complex possesses distinct features overlaying a conserved structural core SO Obado, M Brillantes, W Zhang, K Uryu, NE Ketaren, MC Field, ... MOLECULAR BIOLOGY OF THE CELL 26, 2015 | 1 | 2015 |
| Anti-ETX Nanobodies: Innovative Tools for MS Research, Diagnosis and Therapy E Campisi, KR Rumah, P Fridy, N Ketaren, K Molloy, M Rout, B Chait, ... MULTIPLE SCLEROSIS JOURNAL 29, 239-239, 2023 | | 2023 |
| Unique Binding and Stabilization Mechanisms Employed By and Engineered Into Nanobodies. NE Ketaren, PC Fridy, V Malashkevich, T Sanyal, M Brilliantes, ... bioRxiv, 2023.10. 22.563475, 2023 | | 2023 |
| Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice P Olivier, F Mast, P Fridy, N Ketaren, L Miller, T Sanyal, M Rout, B Chait, ... The Journal of Biological Chemistry 299 (3), 104200, 2023 | | 2023 |
| Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 (preprint) PC Fridy, NE Ketaren, J Wang, EY Jacobs, T Sanyal, KR Molloy, ... | | 2021 |
| Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 (preprint) FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ... | | 2021 |
| Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 PC Fridy, NE Ketaren, J Wang, EY Jacobs, T Sanyal, KR Molloy, ... | | 2021 |
| Attempting to Discover the Secrets of Nanobodies D Kirillova, V Petrusenko, K Ruciński, N Dagaev, O Baranov, A Kolos, ... | | |
| ONE IN THE FIELD IS NOT A WARRIOR: Working with Nanobody Polyclonals L Avetisyan, A Koida, T Potelova, E Shuvalova, Y Dou, N Ketaren | | |
